Table of Contents
Is it good time to invest in Aurobindo Pharma?
Despite the lacklustre numbers for the first quarter of 2021-22, analysts are increasing their bets on Aurobindo Pharma for various reasons. The high base effect—Aurobindo reported revenue and net profit growths of 9\% and 23\% respectively during the first quarter of 2020-21—is the main reason for this.
Is Aurobindo Pharma Debt Free?
In fiscal year 2021, Aurobindo Pharma Limited had -0.04 debt to equity ratio, which was a decrease from the previous financial year. The pharmaceutical company recorded a revenue of over 247.74 billion Indian rupees in financial year 2021.
Is the share market open today?
NSE or National Stock Exchange is open on the weekdays from Monday to Friday and is closed on Saturday and Sunday, except any special trading sessions are announced.
What time should I buy stocks?
The opening 9:30 a.m. to 10:30 a.m. ET period is often one of the best hours of the day for day trading, offering the biggest moves in the shortest amount of time. A lot of professional day traders stop trading around 11:30 a.m. because that is when volatility and volume tend to taper off.
In India, investors can trade in assets and securities even after the stock markets close. The Securities and Exchanges Board of India (SEBI) authorises traders to indulge in trading outside of regular trading hours through an investment tool known as the after trading hours.
Is Aurobindo Pharma a good stock to buy?
Aurobindo Pharma is a fundamentally strong company and if you are a long term investor then his stock can be a good investment. This company is also working on a COVID drug that has been shortlisted for BIRAC funding. This is a plus point for the stock.
Why choose Aurobindo for R&D?
With multiple facilities approved by leading regulatory agencies such as USFDA, EU GMP, UK MHRA, South Africa-MCC, Health Canada, WHO and Brazil ANVISA, Aurobindo makes use of in-house R&D for rapid filing of patents, Drug Master Files (DMFs), Abbreviated New Drug Applications (ANDAs) and formulation dossiers across the world.
What is the debt to equity ratio of Aurobindo Pharma?
So, Debt to Equity ratio is important to analyze the company’s sustainability. Aurobindo Pharma has a Debt to Equity ratio of 0.25 , which is a strong indication for the company.
Is auropharma a good stock to invest in?
Yes, Auropharma is a good stock to invest. The stock is trading at its multi year high currently. The stock might touch its 5years high of 895 in the next few months. But don’t expect this to happen immediately. If you are planning to invest for long term then you can go for this stock.